General Information of the Compound
| Compound ID |
CP0575351
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(1R,9S,12R)-13-[8-[3-(4,4-difluoropiperidin-1-yl)propylamino]-3-methyl-[1,2,4]triazolo[4,3-b]pyridazine-6-carbonyl]-12-propan-2-yl-11,13-diazatricyclo[7.3.1.02,7]trideca-2,4,6-trien-10-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C29H36F2N8O2
|
||||||||||||||||||
| Molecular Weight |
566.657
|
||||||||||||||||||
| Canonical SMILES |
CC(C)[C@H]1NC(=O)[C@@H]2Cc3ccccc3[C@H]1N2C(=O)c1cc(NCCCN2CCC(F)(F)CC2)c2nnc(C)n2n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C29H36F2N8O2/c1-17(2)24-25-20-8-5-4-7-19(20)15-23(27(40)33-24)38(25)28(41)22-16-21(26-35-34-18(3)39(26)36-22)32-11-6-12-37-13-9-29(30,31)10-14-37/h4-5,7-8,16-17,23-25,32H,6,9-15H2,1-3H3,(H,33,40)/t23-,24+,25+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
MMNMOVIEDRHEDO-ISJGIBHGSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03639, ATPase family AAA domain-containing protein 2
Protein ID: PT01462, Bromodomain-containing protein 4